News About: Pharm. Industry
Korean generic makers win Plavix patent lawsuit
Korea's 17 generic makers have won the right to market Plavix (clopidogrel bisulfate) as a local patent court ruled on January 18 that Sanofi-Aventis's original patent is already expired.
However, experts say that ...
Drug makers to vie for big pies over Plavix market
The country's generic makers will be in a fierce race to snatch up a bigger market share of Plavix (clopidogrel bisulfate) as the patent court has upheld that Korean makers' generic clopidogrel bisulfate does not infr...
Norvasc price to lower 20% in January
The current drug price of Pfizer's Norvasc (amlodipine besylate) is likely to be reduced by 20 percent within this month, as its first generic version is covered by the national health insurance.
When a generic dru...
Kukje's first amlodipine generic gets 68% of original brand's price
Kukje Pharm said on January 21 that it has launched its amlodipine besylate 5 mg tablets at the insurance price of 355 won per tablet, a 68-percent price level of Norvasc.
Amlodipine besylate belongs to a group of ...
Diovan takes on Norvasc
Novartis Korea is enjoying brisk sales of its antihypertensive agent, Diovan (valsartan).
Sales of Novartis Korea's antihypertensive medicine are estimated at 78 billion won last year, making it one of the top-sell...
Suspicions raised over sudden cancellation of drug price probe
Despite the government's determination to investigate unfair business transaction of 14 drug makers and 8 wholesalers through the alleged price fixing, the news that the recently formed task force team cancelled its i...
Korea's ethical sales top 7.3 trillion won in 2007
The domestic ethical market for outpatients came to 7.3 trillion won last year, up 11.2 percent over the previous year as major pharmaceutical firms, including Dong-A Pharm and Yuhan Corp., increased their share of th...
Boryung to step up presence in domestic market
Boryung plans to solidify its market position in the domestic market by launching new drug and promoting its flagship products including Gelfos-M and Cilalong, according to a senior official who announced its manageme...
Ilyang Pharm CEO steps down
Ilyang Pharm announced on January 17 that its chief executive officer Yoo Tai-sook resigned.
Under Yoo's resignation, Ilyang Chairman Chung Do-Un, a joint CEO, will be solely responsible for the company management....
Korean biotechnology industry to expand 20% by 2020
Korea's biotechnology industry is expected to grow 19 percent by 2020 on an annual basis, the Korea Development Bank said recently.
According to the bank, Korea's biotechnology industry on an average has been growi...
